AURA
Price
$7.01
Change
-$0.10 (-1.41%)
Updated
Jul 31 closing price
Capitalization
725.09M
3 days until earnings call
Intraday BUY SELL Signals
CNSP
Price
$5.72
Change
+$0.75 (+15.09%)
Updated
Jul 31 closing price
Capitalization
8.5M
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs CNSP

AURA vs CNSP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AURA vs. CNSP commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and CNSP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (AURA: $7.01 vs. CNSP: $5.72)
Brand notoriety: AURA and CNSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 33% vs. CNSP: 48%
Market capitalization -- AURA: $725.09M vs. CNSP: $8.5M
AURA [@Biotechnology] is valued at $725.09M. CNSP’s [@Biotechnology] market capitalization is $8.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileCNSP’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • CNSP’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than CNSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 5 TA indicator(s) are bullish while CNSP’s TA Score has 7 bullish TA indicator(s).

  • AURA’s TA Score: 5 bullish, 3 bearish.
  • CNSP’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -0.57% price change this week, while CNSP (@Biotechnology) price change was +9.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

AURA is expected to report earnings on Aug 06, 2026.

CNSP is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($725M) has a higher market cap than CNSP($8.5M). AURA YTD gains are higher at: 28.624 vs. CNSP (8.952). CNSP has higher annual earnings (EBITDA): -16.47M vs. AURA (-117.51M). AURA has more cash in the bank: 115M vs. CNSP (2.95M). CNSP has less debt than AURA: CNSP (232K) vs AURA (17M). AURA (0) and CNSP (0) have equivalent revenues.
AURACNSPAURA / CNSP
Capitalization725M8.5M8,528%
EBITDA-117.51M-16.47M714%
Gain YTD28.6248.952320%
P/E RatioN/A0.00-
Revenue00-
Total Cash115M2.95M3,897%
Total Debt17M232K7,328%
FUNDAMENTALS RATINGS
CNSP: Fundamental Ratings
CNSP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURACNSP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
CNSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMGDX40.650.84
+2.11%
Allspring Emerging Markets Equity R6
MBNAX33.460.05
+0.15%
NYLI Balanced Class A
WSMDX30.02-0.05
-0.17%
William Blair Small-Mid Cap Growth I
FSMDX42.33-0.12
-0.28%
Fidelity Mid Cap Index
BNUEX13.77-0.12
-0.86%
UBS International Sustainable Equity P

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-1.41%
MGTX - AURA
45%
Loosely correlated
-1.59%
VIR - AURA
44%
Loosely correlated
-2.70%
RCUS - AURA
44%
Loosely correlated
-0.21%
MLTX - AURA
44%
Loosely correlated
-2.90%
CADL - AURA
42%
Loosely correlated
+1.42%
More

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with PMN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
+15.09%
PMN - CNSP
51%
Loosely correlated
-8.04%
RLYB - CNSP
42%
Loosely correlated
-0.87%
ORMP - CNSP
38%
Loosely correlated
-1.21%
AURA - CNSP
33%
Loosely correlated
-1.41%
PTGX - CNSP
30%
Poorly correlated
-1.44%
More